InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,823.52
(
0.27%
)
US TECH 100
19,818.00
(
0.03%
)
Dow Jones
42,387.57
(
0.65%
)
Brent Oil
71.66
(
-1.37%
)
Bitcoin
69,812.90
(
2.79%
)
Post# of 176
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 258
Posts 18261
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: None

Tuesday, 12/24/2019 4:35:51 AM

Tuesday, December 24, 2019 4:35:51 AM

Post# of 176
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152943733

BXDX Meloxicam IV formulation incorporates ALKS Nanocrystal technology
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ALKS News
More ALKS News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Shares Further Advances With Chachas Community on Lucero Surface Rights, Provides Corporate Update • Oct 28, 2024 10:25 AM

VAYK Clarifies It Has No Business Connection to Persons Under SEC Charge • VAYK • Oct 28, 2024 11:59 AM

Vocodia Enters Medical Alert Industry with Innovative Emergency Response Pendant • VHAI • Oct 25, 2024 8:00 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 • HYDI • Oct 24, 2024 11:18 AM

VAYK Asserts Goal of Q4 Operationally Profitable and Projects Major 2025 Launch • VAYK • Oct 24, 2024 10:40 AM

CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push • CBDL • Oct 24, 2024 7:07 AM

Start posting your company's news
Only $200 per official company press release!